Britain loses medicines contracts as EU body anticipates Brexit

European Medicines Agency ends pharma evaluations work and moves contracts to blocBritain ’s leading role in evaluating new medicines for sale to patients across the EU has collapsed with no more work coming from Europe because of Brexit, it has emerged.The decision by theEuropean Medicines Agency to cut Britain out of its contracts seven months ahead of Brexit is a devastating blow to British pharmaceutical companies already reeling from the loss of the EMA ’s HQ in London and with it 900 jobs.Continue reading...

Source: Guardian Unlimited Science - September 2, 2018 Category: Science Authors: Lisa O'Carroll and Hannah Devlin Tags: Pharmaceuticals industry Brexit Medical research UK news European Union Business Science Source Type: news